Resting Energy Expenditure and Substrate Consumption in Cardiac Arrest Patients Under Target Temperature Management

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTang Ziren

About this trial

This study is a single-center, prospective, observational study. According to the sample size formula, an estimated 40 cases should be collected, all of whom are from the emergency intensive care unit. After successful cardiopulmonary resuscitation, the enrolled patients will be transferred to the emergency intensive care unit for further standardized target temperature management (TTM). They will be divided into 33 ° C hypothermia group and 36 ° C hypothermia group according to the patient's core body temperature. The baseline data of the patients will be collected at the beginning. After admission to the hospital, they were fasted within 24 hours to reach the target temperature, and then 20kcal/kg/d parenteral nutrition will be given. At selected time points (T0: the initial time point before TTM; T1: the core temperature was reduced to 33 ° C or 36 ° C; T2-T4: 33 ° C or 36 ° C was maintained for 24h, 48h, 72h; T5: the end of rewarming; Tend: the last REE measurement before discharge or death) , various observation indicators will be collected, including resting energy expenditure (REE), glucose oxidation rate, fat oxidation rate, protein oxidation rate, and metabolism of three major nutrients Proportion. Neurological outcomes were followed up 28 days after onset according to the Cerebral Performance Categories (CPC) score.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Be admitted to the emergency department of Beijing Chao-yang Hospital, Capital Medical University;

Successfully resuscitated, and are unconscious after restoration of spontaneous circulation (ROSC);

Be admitted to the intensive care unit (ICU) for advanced life support such as endotracheal intubation after restoration of spontaneous circulation (ROSC);

Accepted target temperature management (TTM) therapy after restoration of spontaneous circulation (ROSC);

Disqualifiers

Age > 18 years old;

Incomplete clinical data and loss of follow-up;

Traumatic brain injury or cerebrovascular accident revealed by computed tomography (CT);

Severe metabolic abnormalities are known: cachexia, thyroid dysfunction, and cancer;

Trial population

Adult patients(age \>18 years) who have been successfully resuscitated from cardiac arrest who meet the inclusion criteria.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Target Temperature Management Treatment

    Procedure/Surgery

    Target Temperature Management Treatment

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: 33℃ group1 intervention
Group B: 36℃ group1 intervention

Trial outcomes

Primary outcomes

1

Resting Energy Expenditure

The primary outcome measure is the changes resting energy expenditure(REE) in the patients at various time points. patients at various time points.

Time frame
7 days
2

Glucose oxidation rate

The primary outcome measure is the statistical differences in Glucose oxidation rate between the two groups of patients at various time points.

Time frame
7 days
3

Fat oxidation rate

The primary outcome measure is the statistical differences in fat oxidation rate between the two groups of patients at various time points.

Time frame
7 days
4

Protein oxidation rate

The primary outcome measure is the statistical differences in protein oxidation rate between the two groups of patients at various time points.

Time frame
7 days

Secondary outcomes

1

CPC score

CPC = Cerebral Performance Category Score.There are 5 levels of CPC score. CPC 1-2 means good prognosis of neurological function, CPC3-5 means bad prognosis of neurological function. The Secondary Outcome of the study is the statistical differences in the proportion of patients with good neurological outcome(CPC1-2) in the two groups at 28 days after CA.

Time frame
28 days
2

Mortality rate

The Secondary Outcome of the study is the statistical differences in the mortality rate of two groups at 28 days after CA.

Time frame
28 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tang Ziren

Lead sponsor

Capital Medical University

Sponsor institution